TP53 and breast carcinoma: Moreover, patients with breast cancer had significantly worse outcomes (Fig 5d and Tables AG and AH in S1 Table), suggesting that these mutations are more aggressive than other mutations in TP53 and that maybe different therapeutic approaches are needed in these cases.